Publication:
Good Response to Tofacitinib in Refractory Amyopathic Dermatomyositis.

dc.contributor.authorCrespo Cruz, A
dc.contributor.authorDel Boz, J
dc.contributor.authorRomero Gómez, C
dc.date.accessioned2023-02-09T09:45:43Z
dc.date.available2023-02-09T09:45:43Z
dc.date.issued2020-10-27
dc.identifier.doi10.1016/j.ad.2019.07.016
dc.identifier.essn2173-5778
dc.identifier.pmid33127420
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.ad.2019.07.016
dc.identifier.urihttp://hdl.handle.net/10668/16506
dc.issue.number4
dc.journal.titleActas dermo-sifiliograficas
dc.journal.titleabbreviationActas Dermosifiliogr (Engl Ed)
dc.language.isoen
dc.language.isoes
dc.organizationHospital Costa del Sol
dc.organizationÁrea de Gestión Sanitaria Sur de Sevilla
dc.organizationAGS - Sur de Sevilla
dc.page.number374-376
dc.pubmedtypeCase Reports
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshDermatomyositis
dc.subject.meshHumans
dc.subject.meshPiperidines
dc.subject.meshPyrimidines
dc.subject.meshPyrroles
dc.titleGood Response to Tofacitinib in Refractory Amyopathic Dermatomyositis.
dc.title.alternativeDermatomiositis amiopática refractaria con buena respuesta a tofacitinib.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number112
dspace.entity.typePublication

Files